Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
133
-
Total 13F shares, excl. options
-
60.7M
-
Shares change
-
+13.4M
-
Total reported value, excl. options
-
$665M
-
Value change
-
+$151M
-
Put/Call ratio
-
0.16
-
Number of buys
-
64
-
Number of sells
-
-73
-
Price
-
$10.96
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q1 2017
162 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q1 2017.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60.7M shares
of 106M outstanding shares and own 57.31% of the company stock.
Largest 10 shareholders include FEDERATED INVESTORS INC /PA/ (14.6M shares), INGALLS & SNYDER LLC (7.84M shares), BlackRock Inc. (6.9M shares), Consonance Capital Management LP (5.17M shares), VANGUARD GROUP INC (3.75M shares), RENAISSANCE TECHNOLOGIES LLC (1.86M shares), STATE STREET CORP (1.61M shares), Invesco Ltd. (1.32M shares), MORGAN STANLEY (1.31M shares), and ACADIAN ASSET MANAGEMENT LLC (1.11M shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.